Skip to main content
Log in
Adis

Diabetes Therapy

Research, treatment and education of diabetes and related disorders

Publishing model:
Open access

Overview

Diabetes Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, dedicated to the publication of high-quality clinical, observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions, including devices, across all areas of diabetes. The key features of the journal are:

Rapid publication: The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online.
Open access: All articles published open access (CC-BY-NC)
Inclusivity: All scientifically sound research considered be it positive, confirmatory or negative data. Research is considered from pre-clinical, clinical phase, real-world and health economics outcomes studies. Submissions are welcomed whether they relate to an international or a country-specific audience.
Personal service: The journal’s team will re-format articles and upload submissions on behalf of authors, if necessary.
Digital Features and Plain Language Summaries: These peer-reviewed features are welcomed to help enhance the educational value of a manuscript (for more information see “Author Information – Guidelines for digital features and plain language summaries” under “Submission guidelines”).
Publication fees: Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €5500/$6850/£4700. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis. If you would like to request a discount or waiver please do so either ahead of submission or at the very start of the submission process. Requests made after this stage will not be considered. There is an additional fee for podcast articles.
Contact: For more information about the journal, including pre-submission enquiries, please contact Charley Lai: charley.lai@springer.com

Co-Editors-in-Chief
  • Marc Evans
Co-Editor-in-Chief
  • Fernando Ovalle
Journal Impact Factor
2.8 (2023)
5-year Journal Impact Factor
2.9 (2023)
Submission to first decision (median)
2 days
Downloads
1,115,780 (2023)

Latest articles

Journal information

Electronic ISSN
1869-6961
Print ISSN
1869-6953
Abstracted and indexed in
  1. Baidu
  2. CLOCKSS
  3. CNKI
  4. CNPIEC
  5. Chemical Abstracts Service (CAS)
  6. Chinese Academy of Sciences (CAS) - GoOA
  7. DOAJ
  8. Dimensions
  9. EBSCO
  10. EMBASE
  11. Gale
  12. Google Scholar
  13. Naver
  14. Norwegian Register for Scientific Journals and Series
  15. OCLC WorldCat Discovery Service
  16. Portico
  17. ProQuest
  18. PubMedCentral
  19. Reaxys
  20. SCImago
  21. SCOPUS
  22. Science Citation Index Expanded (SCIE)
  23. Semantic Scholar
  24. TD Net Discovery Service
  25. UGC-CARE List (India)
  26. Wanfang
Copyright information

Rights and permissions

Editorial policies

© Springer Healthcare Ltd., part of Springer Nature

Navigation